World leader in silicon innovation selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Natick, MA, April 28, 2008 – clinivation, Inc. announced today that Intel Corporation (NASDAQ: INTC) has selected clinivation WorldView® Online Regulatory Intelligence web service.
“Intel is clearly a leader in developing technologies, products and initiatives to continually advance how people work and live,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions. “We are very pleased that senior management has selected clinivation WorldView as their source for worldwide regulatory intelligence,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Intel Corporation
Intel Corporation is a semiconductor chip maker, developing advanced integrated digital technology products, primarily integrated circuits, for industries, such as computing and communications. The Company’s products include chips, boards and other semiconductor products that are the building blocks integral to computers, servers, consumer electronics and handheld devices, and networking and communications products. Its primary component-level products include microprocessors, chipsets and flash memory.
The Company offers products at various levels of integration, allowing its customers the capability to create advanced computing and communications systems and products. As of December 29, 2007, the Company’s operating segments included the Digital Enterprise Group (DEG), Mobility Group, NAND Products Group, Flash Memory Group, Digital Home Group, Digital Health Group and Software Solutions Group. The Digital Health Group will develop products and explore business opportunities for Intel architecture products in health care research, diagnostics and productivity, as well as personal health care.
For more information, please visit http://www.intel.com.